Skip to main content
. 2021 Dec 29;23(1):340. doi: 10.3390/ijms23010340

Figure 5.

Figure 5

Graph bars represent the mean ± SEM of (a) α-SMA+, (b) Myh11+MAC2+ expression and (c) Myh11+LipidTOX+ (foam cells) formation of VSMCs upon oxLDL and IL-β treatment as indicated, with n  =  6/group and * p  < 0.05, ** p < 0.01, *** p  <  0.001. Graph bars represent the mean ± SEM of (d) α-SMA+, (e) Myh11+MAC2+, expressed as mean fluorescence intensity and (f) Myh11+LipidTOX+ (foam cells) expressed as a percentage of a alive VSMC upon oxLDL and/or IL-β and/or ZVAD treatment as indicated, with n  =  6/group and * p  <  0.05, ** p  <  0.01, *** p  <  0.001, one-way ANOVA. (g) Representative flow cytometry zebra plots of Myh11+MAC2+ cells. Graph bars represent the mean ± SEM of (h) Myh11+, (i) F4/80+ expressed as mean fluorescence intensity and (j) Myh11+F4/80+ as a percentage of alive VSMC upon oxLDL and/or IL-β and/or MCC950 treatment as indicated, with n  =  6/group and * p  <  0.05, ** p  <  0.01, *** p  <  0.001, one-way ANOVA.